| Year |
Citation |
Score |
| 2023 |
Lee E, Coulter J, Mishra A, Caramella-Pereira F, Demarzo A, Rudek M, Hu C, Han M, DeWeese TL, Yegnasubramanian S, Song DY. Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind prospective trial. Trials. 24: 809. PMID 38104131 DOI: 10.1186/s13063-023-07838-4 |
0.479 |
|
| 2023 |
Graham MK, Wang R, Chikarmane R, Wodu B, Vaghasia A, Gupta A, Zheng Q, Hicks J, Sysa-Shah P, Pan X, Castagna N, Liu J, Meyers J, Skaist A, Zhang Y, ... ... DeWeese TL, et al. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer. Biorxiv : the Preprint Server For Biology. PMID 37905029 DOI: 10.1101/2023.09.07.553268 |
0.831 |
|
| 2023 |
Hoang T, Sutera P, Nguyen T, Chang J, Jagtap S, Song Y, Shetty AC, Chowdhury DD, Chan A, Carrieri FA, Hathout L, Ennis R, Jabbour SK, Parikh R, Molitoris J, ... ... DeWeese T, et al. TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment. The Prostate. PMID 37812042 DOI: 10.1002/pros.24629 |
0.354 |
|
| 2023 |
Sutera P, Shetty AC, Song Y, Hodges T, Hoang T, Rana Z, Pienta K, Feng F, Song DY, DeWeese T, Gillessen S, Sweeney C, James N, Attard G, Deek M, et al. Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer. European Urology Oncology. PMID 37558543 DOI: 10.1016/j.euo.2023.07.014 |
0.432 |
|
| 2023 |
Sutera P, Song Y, Van der Eecken K, Shetty AC, English K, Hodges T, Chang J, Fonteyne V, Rana Z, Ren L, Mendes AA, Lumen N, Delrue L, Verbeke S, De Man K, ... ... DeWeese T, et al. Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer. European Urology. PMID 37173210 DOI: 10.1016/j.eururo.2023.04.025 |
0.375 |
|
| 2023 |
LaVigne AW, DeWeese TL, Wright JL, Deville C, Yegnasubramanian S, Alcorn SR. Radiotherapy Deserts: Impact of Race, Poverty and the Rural-Urban Continuum on Density of Providers and Utilization of Radiotherapy in the United States. International Journal of Radiation Oncology, Biology, Physics. PMID 36736631 DOI: 10.1016/j.ijrobp.2023.01.046 |
0.58 |
|
| 2023 |
Sutera P, Deek MP, Van der Eecken K, Shetty AC, Chang JH, Hodges T, Song Y, Verbeke S, Van Dorpe J, Fonteyne V, De Laere B, Mishra M, Rana Z, Molitoris J, Ferris M, ... ... DeWeese T, et al. WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 36708787 DOI: 10.1016/j.ijrobp.2022.12.006 |
0.409 |
|
| 2022 |
Graham MK, Chikarmane R, Wang R, Vaghasia A, Gupta A, Zheng Q, Wodu B, Pan X, Castagna N, Liu J, Meyers J, Skaist A, Wheelan S, Simons BW, Bieberich C, ... ... DeWeese TL, et al. Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate. The Prostate. PMID 36373171 DOI: 10.1002/pros.24460 |
0.808 |
|
| 2022 |
Tran PT, Lowe K, Tsai HL, Song DY, Hung AY, Hearn JWD, Miller S, Proudfoot JA, Deek MP, Phillips R, Lotan T, Paller CJ, Marshall CH, Markowski M, Dipasquale S, ... ... DeWeese TL, et al. Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201662. PMID 36367998 DOI: 10.1200/JCO.22.01662 |
0.464 |
|
| 2022 |
Lee EE, Singh T, Hu C, Han M, Deville CJ, Halthore A, Greco S, Tran P, DeWeese T, Song DY. The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy. The Prostate. PMID 36316967 DOI: 10.1002/pros.24452 |
0.449 |
|
| 2022 |
Patel SA, Ma TM, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, ... ... DeWeese TL, et al. External Beam Radiotherapy With or Without Brachytherapy Boost in Men with Very High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. International Journal of Radiation Oncology, Biology, Physics. PMID 36179990 DOI: 10.1016/j.ijrobp.2022.09.075 |
0.409 |
|
| 2022 |
Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, ... ... DeWeese TL, et al. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. Jama Oncology. PMID 35050303 DOI: 10.1001/jamaoncol.2021.6871 |
0.431 |
|
| 2022 |
Cao Y, Song DY, Deville C, DeWeese TL, Greco S, Tran PT, Deek MP. Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be? The Prostate. 82: 551-555. PMID 35014708 DOI: 10.1002/pros.24301 |
0.467 |
|
| 2022 |
Sutera P, Van Der Eecken K, Kishan AU, Hamid A, Grist E, Attard G, Lotan T, Mendes AA, Paller CJ, Carducci MA, Ross A, Wang H, Pienta K, Feng FY, Antonarakis ES, ... ... DeWeese T, et al. Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics. Prostate Cancer and Prostatic Diseases. PMID 35013522 DOI: 10.1038/s41391-021-00484-4 |
0.371 |
|
| 2022 |
Coulter JB, Song DY, DeWeese TL, Yegnasubramanian S. Mechanisms, Challenges, and Opportunities in Combined Radiation and Hormonal Therapies. Seminars in Radiation Oncology. 32: 76-81. PMID 34861998 DOI: 10.1016/j.semradonc.2021.09.003 |
0.811 |
|
| 2021 |
Xiang M, Ma TM, Savjani R, Pollom EL, Karnes RJ, Grogan T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, ... ... DeWeese TL, et al. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. Jama Network Open. 4: e2138550. PMID 34902034 DOI: 10.1001/jamanetworkopen.2021.38550 |
0.302 |
|
| 2021 |
Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, ... ... DeWeese TL, et al. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. Jama Network Open. 4: e2115312. PMID 34196715 DOI: 10.1001/jamanetworkopen.2021.15312 |
0.387 |
|
| 2021 |
Mishra A, Zennami K, Velarde E, Thorek DLJ, Yegnasubramanian S, DeWeese TL, Lupold SE. Longitudinal measurement of subcutaneous and intratibial human prostate cancer xenograft growth and response to ionizing radiation by plasma Alu and LINE-1 ctDNA: A comparison to standard methods. The Prostate. PMID 34032307 DOI: 10.1002/pros.24171 |
0.617 |
|
| 2021 |
Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, ... ... DeWeese TL, et al. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. European Urology. PMID 33985797 DOI: 10.1016/j.eururo.2021.04.035 |
0.445 |
|
| 2021 |
Marshall CH, Fu W, Wang H, Park JC, DeWeese TL, Tran PT, Song DY, King S, Afful M, Hurrelbrink J, Manogue CE, Cotogno P, Moldawer NP, Barata P, Drake CG, et al. Randomized phase II trial of sipuleucel-T with or without radium-223 in men with bone-metastatic castration-resistant prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33451978 DOI: 10.1158/1078-0432.CCR-20-4476 |
0.346 |
|
| 2020 |
Deek M, Lilleby W, Vaage V, Hole KH, DeWeese T, Stensvold A, Tran P, Seierstad T. Impact of radiation dose on recurrence in high-risk prostate cancer patients. The Prostate. 80: 1322-1327. PMID 33258482 DOI: 10.1002/Pros.24059 |
0.492 |
|
| 2020 |
Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, ... DeWeese TL, et al. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. Jama Oncology. PMID 33090219 DOI: 10.1001/jamaoncol.2020.4922 |
0.38 |
|
| 2020 |
Wakefield DV, Sanders T, Wilson E, Hubler A, DeWeese T, Smith BD, Slotman BJ, Sarria GR, Eichler T, Schwartz DL. Initial Impact and Operational Responses to the COVID-19 Pandemic by American Radiation Oncology Practices. International Journal of Radiation Oncology, Biology, Physics. 108: 356-361. PMID 32890512 DOI: 10.1016/J.Ijrobp.2020.06.060 |
0.314 |
|
| 2020 |
Deek MP, Taparra K, Dao D, Chan L, Phillips R, Gao RW, Kwon ED, Deville C, Song DY, Greco S, Carducci MA, Eisenberger M, DeWeese TL, Denmeade S, Pienta K, et al. Patterns of Recurrence and Modes of Progression Following Metastasis Directed Therapy in Oligometastatic Castration Sensitive Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 32798608 DOI: 10.1016/J.Ijrobp.2020.08.030 |
0.483 |
|
| 2020 |
Deek MP, Taparra K, Phillips R, Velho PI, Gao RW, Deville C, Song DY, Greco S, Carducci M, Eisenberger M, DeWeese TL, Denmeade S, Pienta K, Paller CJ, Antonarakis ES, et al. Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer. European Urology Oncology. PMID 32536574 DOI: 10.1016/J.Euo.2020.05.004 |
0.46 |
|
| 2020 |
Hasan H, Deek MP, Phillips R, Hobbs RF, Malek R, Radwan N, Kiess AP, Dipasquale S, Huang J, Caldwell T, Leitzel J, Wendler D, Wang H, Thompson E, Powell J, ... ... DeWeese TL, et al. A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS). Bmc Cancer. 20: 492. PMID 32487038 DOI: 10.1186/S12885-020-07000-2 |
0.479 |
|
| 2020 |
Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, ... DeWeese TL, et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. Jama Oncology. PMID 32215577 DOI: 10.1001/Jamaoncol.2020.0147 |
0.552 |
|
| 2020 |
Quinn TJ, Daignault-Newton S, Bosch W, Mariados N, Sylvester J, Shah D, Gross E, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, ... ... DeWeese T, et al. Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial. Practical Radiation Oncology. PMID 31978591 DOI: 10.1016/J.Prro.2019.12.011 |
0.483 |
|
| 2020 |
Wedde T, Cvancarova M, Hayman JS, Tran PT, Tafjord G, DeWeese TL, Lilleby W. PSA status after neoadjuvant androgen deprivation therapy before high-dose-rate brachytherapy as biomarker for prediction of long-term outcome in high-risk prostate cancer patients. Journal of Clinical Oncology. 38: 301-301. DOI: 10.1200/Jco.2020.38.6_Suppl.301 |
0.474 |
|
| 2020 |
Deek M, Vaage V, Hole KH, DeWeese TL, Stensvold A, Seierstad T, Tran PT, Lilleby W. Testosterone recovery as biomarker for overall and cause-specific survival in combined treated patients with high-risk and locally advanced prostate cancer. Journal of Clinical Oncology. 38: 188-188. DOI: 10.1200/Jco.2020.38.6_Suppl.188 |
0.471 |
|
| 2020 |
Marshall CH, Park JC, DeWeese TL, King S, Afful M, Hurrelbrink J, Manogue C, Cotogno P, Moldawer NP, Barata PC, Drake CG, Posadas EM, Armstrong AJ, Sartor AO, Antonarakis ES. Randomized phase II study of sipuleucel-T (SipT) with or without radium-223 (Ra223) in men with asymptomatic bone-metastatic castrate-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 38: 130-130. DOI: 10.1200/Jco.2020.38.6_Suppl.130 |
0.413 |
|
| 2020 |
Marshall CH, Park JC, Fu W, Wang H, DeWeese TL, King S, Afful M, Hurrelbrink J, Manogue C, Cotogno P, Moldawer NP, Barata PC, Drake CG, Posadas EM, Armstrong AJ, et al. Results of the randomized phase II study of sipuleucel-T (Sip-T) +/- Radium-223 (Ra-223) in men with bone-metastatic castration resistant prostate cancer. Journal of Clinical Oncology. 38: 5563-5563. DOI: 10.1200/Jco.2020.38.15_Suppl.5563 |
0.415 |
|
| 2020 |
Taparra K, Deek M, Dao D, Chan L, Phillips R, Isaacsson Velho P, Gao R, Deville C, Song D, Greco S, Carducci M, Eisenberger M, DeWeese T, Denmeade S, Pienta K, et al. Modes of Failure Following Metastasis Directed Therapy in Patients with Oligometastatic Hormone Sensitive Prostate Cancer: A Multi-institutional Analysis International Journal of Radiation Oncology*Biology*Physics. 108: e869-e870. DOI: 10.1016/j.ijrobp.2020.07.447 |
0.366 |
|
| 2019 |
Phillips RM, Deek MP, Deweese TL, Tran PT. Metastasis-Directed Therapy in Prostate Cancer. Why, When, and How? Oncology (Williston Park, N.Y.). 33. PMID 31661149 |
0.426 |
|
| 2019 |
Peng LC, Mian OY, Lakshminarayanan P, Huang P, Bae HJ, Robertson S, Habtu T, Narang A, Agarwal S, Greco S, Tran P, McNutt T, DeWeese TL, Song DY. Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer. Urology. PMID 31454660 DOI: 10.1016/J.Urology.2019.08.014 |
0.477 |
|
| 2019 |
Deek MP, Yu C, Phillips R, Song DY, Deville C, Greco S, DeWeese TL, Antonarakis ES, Markowski M, Paller C, Denmeade S, Carducci M, Walsh PC, Pienta KJ, Eisenberger M, et al. Radiotherapy In The Definitive Management Of Oligometastatic Prostate Cancer: The Johns Hopkins Experience. International Journal of Radiation Oncology, Biology, Physics. PMID 31419509 DOI: 10.1016/J.Ijrobp.2019.08.008 |
0.515 |
|
| 2019 |
Kapoor R, Deek MP, McIntyre R, Raman N, Kummerlowe M, Chen I, Gaver M, Wang H, Denmeade S, Lotan T, Paller C, Markowski M, Carducci M, Eisenberger M, Beer TM, ... ... DeWeese TL, et al. A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA). Bmc Cancer. 19: 572. PMID 31196032 DOI: 10.1186/S12885-019-5805-Z |
0.517 |
|
| 2019 |
Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, ... ... DeWeese TL, et al. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. European Urology. PMID 30992160 DOI: 10.1016/J.Eururo.2019.03.022 |
0.55 |
|
| 2019 |
Marciscano AE, Haimovitz-Friedman A, Lee P, Tran PT, Tomé WA, Guha C, Kong FS, Sahgal A, El Naqa I, Rimner A, Marks LB, Formenti SC, DeWeese TL. Immunomodulatory Effects of Stereotactic Body Radiation Therapy (SBRT): Preclinical Insights and Clinical Opportunities. International Journal of Radiation Oncology, Biology, Physics. PMID 30836168 DOI: 10.1016/J.Ijrobp.2019.02.046 |
0.343 |
|
| 2019 |
Phillips R, Lim S, Shi W, Antonarakis E, Rowe S, Gorin M, Deville C, Greco S, Denmeade S, Paller C, DeWeese T, Song D, Wang H, Carducci M, Pienta K, et al. Primary Outcomes of a Phase II Randomized Trial of Observation Versus Stereotactic Ablative RadiatIon for OLigometastatic Prostate CancEr (ORIOLE) International Journal of Radiation Oncology*Biology*Physics. 105: 681. DOI: 10.1016/J.Ijrobp.2019.08.031 |
0.486 |
|
| 2019 |
Dess RT, Suresh K, Zelefsky MJ, Cooperberg MR, Mahal BA, Davis BJ, Horwitz EM, DeWeese TL, Song D, Berlin A, Moraes F, Briganti A, Gandaglia G, Freedland SJ, Feng FY, et al. Development and Validation of the First AJCC Compliant Clinical Staging System for Localized Prostate Cancer: Results from a Multicenter International Study International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.461 |
0.484 |
|
| 2019 |
Kishan AU, Wong JK, Romero T, Grogan T, Tendulkar RD, Reddy CA, Dess RT, Levin-Epstein R, Wedde T, Lilleby W, Merrick GS, Stock RG, Krauss DJ, Tran PT, DeWeese TL, et al. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost: Comparison of Outcomes in A Multi-Institutional Analysis of 4,086 Patients with High-Risk Prostate Cancer International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.460 |
0.43 |
|
| 2019 |
Phillips R, Hasan H, Huang J, Di Pasquale S, Kumar R, Deek M, Yu C, DeWeese T, Han M, Gorin M, Asrari F, Deville C, Greco S, Song D, Tran P. Stereotactic Ablative Radiation and Short-Term Androgen Ablation for Intermediate-Risk Localized Prostate Adenocarcinoma: Safety and Toxicity From a Prospective Single-Arm Phase II Trial (NCT01517451) International Journal of Radiation Oncology*Biology*Physics. 105: E302-E303. DOI: 10.1016/J.Ijrobp.2019.06.1858 |
0.449 |
|
| 2019 |
Yu C, Deek M, Phillips R, Song D, Deville C, Greco S, DeWeese T, Antonarakis E, Markowski M, Paller C, Denmeade S, Carudcci M, Pienta K, Eisenberger M, Tran P. Clinical Outcomes in Oligometastatic Prostate Cancer Following Definitive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 105: E573-E574. DOI: 10.1016/J.Ijrobp.2019.06.1243 |
0.53 |
|
| 2019 |
Mishra A, Zennami K, Velarde E, Coulter JB, Yegnasubramanian S, Lupold S, DeWeese TL. Circulating Tumor DNA Is an Accurate Measurement of Determining Radiation-Induced Therapeutic Response and Tumor Burden Monitoring in a Prostate Cancer Bone Metastases Murine Model International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1065 |
0.804 |
|
| 2019 |
Deek MP, Yu C, Phillips R, Song D, Deville C, Greco SC, DeWeese TL, Antonarakis ES, Markowski M, Paller C, Denmeade S, Carudcci M, Walsh P, Pienta K, Eisenberger M, et al. Radiotherapy In The Definitive Management Of Oligometastatic Prostate Cancer International Journal of Radiation Oncology Biology Physics. 104: 1194. DOI: 10.1016/J.Ijrobp.2019.05.054 |
0.515 |
|
| 2018 |
Quon H, McNutt T, Lee J, Bowers M, Jiang W, Lakshminarayanan P, Cheng Z, Han P, Hui X, Shah V, Moore J, Nakatsugawa M, Robertson S, Page B, Kiess A, ... ... DeWeese T, et al. Needs and Challenges for Radiation Oncology in the Era of Precision Medicine. International Journal of Radiation Oncology, Biology, Physics. PMID 30562547 DOI: 10.1016/J.Ijrobp.2018.11.017 |
0.386 |
|
| 2018 |
Hayman J, Hole KH, Seierstad T, Perin J, DeWeese TL, Tran PT, Lilleby W. Local failure is a dominant mode of recurrence in locally advanced and clinical node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy. Urologic Oncology. PMID 30446451 DOI: 10.1016/J.Urolonc.2018.09.016 |
0.493 |
|
| 2018 |
Guss ZD, Chen Q, Hu C, Guss LG, DeWeese TL, Terezakis SA. Differences in Physician Compensation between Men and Women at United States Public Academic Radiation Oncology Departments. International Journal of Radiation Oncology, Biology, Physics. PMID 30315874 DOI: 10.1016/J.Ijrobp.2018.09.042 |
0.31 |
|
| 2018 |
Isaacsson Velho P, Qazi F, Hassan S, Carducci MA, Denmeade SR, Markowski MC, Thorek DL, DeWeese TL, Song DY, Tran PT, Eisenberger MA, Antonarakis ES. Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects. European Urology. PMID 30293905 DOI: 10.1016/J.Eururo.2018.09.040 |
0.466 |
|
| 2018 |
Lee J, Hobbs RF, Zahurak M, Ng SK, Zhang Z, Burdette EC, DeWeese TL, Song DY. Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy. Brachytherapy. PMID 30217432 DOI: 10.1016/J.Brachy.2018.07.013 |
0.347 |
|
| 2018 |
Moyer CL, Phillips R, Deek MP, Radwan N, Ross AE, Antonarakis ES, Reyes D, Wright J, Terezakis SA, Song DY, DeVille C, Walsh PC, DeWeese TL, Carducci M, Schaeffer EM, et al. Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment. World Journal of Urology. PMID 30191396 DOI: 10.1007/S00345-018-2477-2 |
0.548 |
|
| 2018 |
Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, ... ... DeWeese TL, et al. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. International Journal of Radiation Oncology, Biology, Physics. 101: 883-888. PMID 29976500 DOI: 10.1016/J.Ijrobp.2018.03.060 |
0.43 |
|
| 2018 |
Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby M, ... ... DeWeese TL, et al. Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29898992 DOI: 10.1158/1078-0432.Ccr-17-3427 |
0.313 |
|
| 2018 |
Peng LC, Narang AK, Gergis C, Radwan NA, Han P, Marciscano AE, Robertson SP, He P, Trieu J, Ram AN, McNutt TR, Griffith E, DeWeese TA, Honig S, Singh H, ... ... DeWeese TL, et al. Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urologic Oncology. PMID 29551548 DOI: 10.1016/J.Urolonc.2018.02.008 |
0.526 |
|
| 2018 |
Anderson R, Armour E, Beeckler C, Briner V, Choflet A, Cox A, Fader AN, Hannah MN, Hobbs R, Huang E, Kiely M, Lee J, Morcos M, McMillan PE, Miller D, ... ... DeWeese TL, et al. Interventional Radiation Oncology (IRO): Transition of a magnetic resonance simulator to a brachytherapy suite. Brachytherapy. PMID 29548553 DOI: 10.1016/J.Brachy.2018.01.007 |
0.326 |
|
| 2018 |
Hayman J, Phillips R, Chen D, Perin J, Narang AK, Trieu J, Radwan N, Greco S, Deville C, McNutt T, Song DY, DeWeese TL, Tran PT. Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality. The Prostate. PMID 29520847 DOI: 10.1002/Pros.23507 |
0.52 |
|
| 2018 |
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, ... ... DeWeese TL, et al. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Jama. 319: 896-905. PMID 29509865 DOI: 10.1001/Jama.2018.0587 |
0.489 |
|
| 2018 |
Giovinazzo H, Reichert ZR, Bergman A, Lin X, Wyhs N, Esopi D, Vaghasia A, Liu J, Jain Y, Bhamidipati A, Steinberg R, Speed T, Vaughn M, Zhang Y, Brennen N, ... Deweese T, et al. Abstract 5881: Novel inhibitors of the epigenetic reader protein MBD2 Cancer Research. 78: 5881-5881. DOI: 10.1158/1538-7445.Am2018-5881 |
0.648 |
|
| 2018 |
Tran P, Radwan N, Phillips R, Ross A, Rowe S, Gorin M, Antonarakis E, DeVille C, Greco S, Denmeade S, Paller C, Song D, Diehn M, Wang H, Carducci M, ... ... DeWeese T, et al. OC-0505: Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer Radiotherapy and Oncology. 127: S261. DOI: 10.1016/S0167-8140(18)30815-6 |
0.393 |
|
| 2018 |
Coulter JB, Haffner MC, Mian OY, Hedayati M, Zhang Y, Zhou H, Mishra A, Nelson W, Song D, Yegnasubramanian S, DeWeese TL. Hydroxyflutamide Induces Androgen Receptor-Mediated DNA Damage and Radiosensitizes Prostate Cancer Cells While Preventing Induction of Pro-Growth Programs International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.667 |
0.823 |
|
| 2018 |
Hazell SZ, Zahurak M, Lee J, DeWeese TL, Song D. Intraoperative Dynamic Dosimetry Using Registered Ultrasound and Fluoroscopy Improves Prostate Brachytherapy Dose Coverage Without Increasing Dose to Normal Tissues International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.317 |
0.416 |
|
| 2018 |
Phillips R, Radwan N, Ross A, Rowe S, Gorin M, Antonarakis E, Deville C, Greco S, Denmeade S, Paller C, Song D, Wang H, Carudcci M, Pienta K, Pomper M, ... DeWeese T, et al. Interim Results of a Randomized Trial of Observation Versus SABR for Castration-Sensitive Oligometastatic Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e134-e135. DOI: 10.1016/J.Ijrobp.2018.07.257 |
0.496 |
|
| 2018 |
Cheng Z, Nicholas SE, Lakshminarayanan P, Cox A, Davis K, Moore C, Beeckler C, Holt J, Morcos M, Kiely M, DeWeese TL, McNutt TR, Viswanathan AN. Comparison of Prospectively-Collected Physician-Reported and Patient-Reported Toxicities Among Gynecological Cancer Patients Receiving Radiation Therapy International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1973 |
0.382 |
|
| 2018 |
Nicholas SE, Fu W, Hu C, Cheng Z, McNutt TR, Cho LP, DeWeese TL, Viswanathan AN. A Comparison of Prospectively Collected Genitourinary and Gastrointestinal Toxicities and Dose Volume Histogram in Patients Treated with Intensity-Modulated Radiation Therapy or Non-Intensity-Modulated Post-Operative Radiation Therapy International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1769 |
0.35 |
|
| 2018 |
Phillips R, Da Silva A, Radwan N, Gorin M, Rowe S, Deville C, Song D, Greco S, Pienta K, Pomper M, DeWeese T, Wong J, Tran P, Wang K. PSMA-Directed Biologically-Guided Radiation Therapy of Castration-Sensitive Oligometastatic Prostate Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 102: S152. DOI: 10.1016/J.Ijrobp.2018.06.367 |
0.555 |
|
| 2018 |
Tran PT, Phillips R, Radwan N, Hether T, Vignali M, Kaplan I, Ross AE, Deville C, Greco SC, Song D, Wang H, Pienta K, DeWeese TL, Dicker AP, Eisenberger M. SABR Produces Systemic Adaptive Immune Responses in Castration-Sensitive Oligometastatic Prostate Cancer Patients International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.06.146 |
0.458 |
|
| 2017 |
Ferro A, Bae HJ, Yenokyan G, Le Y, McNutt T, Mian O, Gergis C, Haviland C, DeWeese TL, Song DY. Reductions in prostatic doses are associated with less acute morbidity in patients undergoing Pd-103 brachytherapy: Substantiation of the rationale for focal therapy. Brachytherapy. PMID 29174937 DOI: 10.1016/J.Brachy.2017.10.008 |
0.427 |
|
| 2017 |
Bae HJ, Mian O, Vaidya D, DeWeese TL, Song DY. Use of 5-alpha-reductase inhibitors as alternatives to luteinizing-hormone releasing hormone (LHRH) analogs or anti-androgens for prostate downsizing before brachytherapy. Practical Radiation Oncology. PMID 29153901 DOI: 10.1016/J.Prro.2017.10.004 |
0.428 |
|
| 2017 |
Rao AD, Coquia S, De Jong R, Gourin C, Page B, Latronico D, Dah S, Su L, Clarke S, Schultz J, Rosati LM, Fakhry C, Wong J, DeWeese TL, Quon H, et al. Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28985953 DOI: 10.1016/J.Radonc.2017.09.017 |
0.379 |
|
| 2017 |
Hamstra DA, Mariados N, Sylvester J, Shah D, Gross E, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, ... ... DeWeese T, et al. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase III trial. Practical Radiation Oncology. PMID 28951089 DOI: 10.1016/J.Prro.2017.07.008 |
0.483 |
|
| 2017 |
Rao AD, Feng Z, Shin EJ, He J, Waters KM, Coquia S, DeJong R, Rosati LM, Su L, Li D, Jackson J, Clark S, Schultz J, Hutchings D, Kim SH, ... ... DeWeese TL, et al. A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 28943075 DOI: 10.1016/J.Ijrobp.2017.08.006 |
0.347 |
|
| 2017 |
Radwan N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H, Carducci M, Pienta KJ, ... ... DeWeese TL, et al. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE). Bmc Cancer. 17: 453. PMID 28662647 DOI: 10.1186/s12885-017-3455-6 |
0.492 |
|
| 2017 |
Lee J, Mian OY, Le Y, Bae HJ, Burdette EC, DeWeese TL, Prince JL, Song DY. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28647400 DOI: 10.1016/J.Radonc.2017.05.018 |
0.431 |
|
| 2017 |
Malek R, Gajula RP, Williams RD, Nghiem B, Simons BW, Nugent K, Wang H, Taparra K, Lemtiri-Chlieh G, Yoon AR, True L, An SS, DeWeese TL, Ross AE, Schaeffer EM, et al. TWIST1-WDR5-Hottip regulates Hoxa9 chromatin to facilitate prostate cancer metastasis. Cancer Research. PMID 28484075 DOI: 10.1158/0008-5472.Can-16-2797 |
0.498 |
|
| 2017 |
Narang AK, Trieu J, Radwan N, Ram A, Robertson SP, He P, Gergis C, Griffith E, Singh H, DeWeese TA, Honig S, Annadanam A, Greco S, DeVille C, McNutt T, ... DeWeese TL, et al. End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 28094250 DOI: 10.1038/Pcan.2016.67 |
0.561 |
|
| 2017 |
Tosoian JJ, Alam R, Gergis C, Narang A, Radwan N, Robertson S, McNutt T, Ross AE, Song DY, DeWeese TL, Tran PT, Walsh PC. Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease. Prostate Cancer and Prostatic Diseases. PMID 28045113 DOI: 10.1038/Pcan.2016.64 |
0.477 |
|
| 2017 |
Hamstra DA, Shah D, Kurtzman S, Sylvester J, Zimberg SH, Hudes RS, Karsh LI, Logsdon MD, Beyer D, Kos M, Hsi RA, Forsythe K, Soffen EM, Francke PM, Zhang H, ... DeWeese TL, et al. Evaluation of sexual function on a randomized trial of a prostate rectal spacer. Journal of Clinical Oncology. 35: 69-69. DOI: 10.1200/Jco.2017.35.6_Suppl.69 |
0.462 |
|
| 2017 |
Tran PT, Moyer CL, Phillips R, Radwan N, Ross A, Reyes DK, Wright J, Antonarakis ES, Song DY, Deville C, Walsh PC, DeWeese TL, Carducci MA, Schaeffer EM, Pienta KJ, et al. Stereotactic ablative radiation therapy for the treatment of oligometastatic prostate cancer. Journal of Clinical Oncology. 35: 5020-5020. DOI: 10.1200/Jco.2017.35.15_Suppl.5020 |
0.562 |
|
| 2017 |
Marciscano AE, Ghasemzadeh A, Nirschl TR, Francica BJ, Theodros D, Velarde E, Wong J, Thorek DL, DeWeese TL, Drake CG. Abstract PR03: Prophylactic nodal irradiation abrogates the synergy of tumor radiotherapy and immune checkpoint blockade Cancer Immunology Research. 5. DOI: 10.1158/2326-6074.Tumimm16-Pr03 |
0.305 |
|
| 2017 |
Malek R, Gajula R, Williams R, Nghiem B, Simons B, Wang H, Taparra K, Barbhuiya M, Deweese T, Pienta K, Hurley P, Morrissey C, Tran P. Targeting Twist1-Hoxa9 to sensitize prostate cancer to PARP inhibition European Urology Supplements. 16: e2719. DOI: 10.1016/S1569-9056(17)31858-4 |
0.501 |
|
| 2017 |
Zennami K, Zhang Y, Zhou H, Thorek D, DeWeese T, Lupold S. MP83-12 TISSUE-SPECIFIC RADIATION SENSITIZATION OF PROSTATE CANCER BY APTAMER TARGETED SIRNA KNOCK-DOWN OF DNA REPAIR PATHWAY Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2580 |
0.525 |
|
| 2017 |
Conley WK, Donovan GK, FitzGerald KT, Guss ZD, Kwok Y, DeWeese TL, Terezakis SA. Risk Tolerance in Radiation Oncology: A Multi-Institutional Survey International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1542 |
0.318 |
|
| 2017 |
Cho LP, Cheng Z, McNutt TR, DeWeese TL, Viswanathan AN. Comparison of Prospectively-Collected Genitourinary and Gastrointestinal Toxicities Between Post-Operative Intensity-Modulated Radiation Therapy and Non-Intensity-Modulated Radiation Therapy Patients International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1286 |
0.339 |
|
| 2017 |
Phillips R, Gorin M, Rowe S, Hayman J, Radwan N, Pomper M, Allaf M, Eisenberger M, Ross A, Pienta K, DeWeese T, Greco S, Song D, Deville C, Tran P. Changes in Radiotherapeutic Management of Prostate Cancer Following PSMA-based 18 F-DCFPyL PET Imaging: A Snapshot of Prospective Trials at a Single Institution International Journal of Radiation Oncology*Biology*Physics. 99: E259-E260. DOI: 10.1016/J.Ijrobp.2017.06.1224 |
0.416 |
|
| 2017 |
Conley WK, Bae H, Narang A, McNutt TR, Greco SC, Asrari F, Deville C, Tran PT, DeWeese TL, Song D. End-of-Treatment PSA Is Frequently Elevated Compared to Baseline PSA Following Hypofractionated Radiation Therapy International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1139 |
0.426 |
|
| 2016 |
Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, ... ... DeWeese T, et al. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. International Journal of Radiation Oncology, Biology, Physics. PMID 28209443 DOI: 10.1016/J.Ijrobp.2016.12.024 |
0.493 |
|
| 2016 |
Marciscano AE, Nirschl TR, Francica BJ, Ghasemzadeh A, Theodros D, Velarde E, Wong JW, Thorek DL, DeWeese TL, Drake CG. Does Prophylactic Nodal Irradiation Inhibit Potential Synergy Between Radiation Therapy and Immunotherapy? International Journal of Radiation Oncology, Biology, Physics. 96: S88. PMID 27676041 DOI: 10.1016/J.Ijrobp.2016.06.222 |
0.35 |
|
| 2016 |
Baig N, Elnahal SM, McNutt TR, Wright JL, DeWeese TL, Terezakis SA. Identifying Risk Factors for Near-Miss Events in Pediatric Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S234. PMID 27675864 DOI: 10.1016/J.Ijrobp.2016.06.581 |
0.315 |
|
| 2016 |
Coulter JB, Haffner MC, Mian OY, Kim K, Hedayati M, Zhang Y, Zhou H, Nelson W, Yegnasubramanian S, DeWeese TL. Partial Agonist Activity of Hydroxyflutamide Induces AR- and TOP2B-dependent DNA Double Strand Breaks and Radiosensitizes Prostate Cancer Cells. International Journal of Radiation Oncology, Biology, Physics. 96: S19. PMID 27675748 DOI: 10.1016/J.Ijrobp.2016.06.059 |
0.831 |
|
| 2016 |
Tran PT, Radwan N, Ross AE, Reyes D, Wright JL, Song D, Deville C, DeWeese TL, Carducci M, Schaeffer EM, Pienta K, Eisenberger M. Stereotactic Ablative Radiation Therapy for the Treatment of Oligometastatic Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E248. PMID 27674170 DOI: 10.1016/J.Ijrobp.2016.06.1247 |
0.552 |
|
| 2016 |
Sadik H, Korangath P, Nguyen N, Győrffy B, Kumar R, Hedayati M, Teo WW, Park S, Panday H, Gonzalez Munoz T, Menyhart O, Shah N, Pandita RK, Chang JC, DeWeese TL, et al. HOXC10 expression supports the development of chemotherapy resistance by fine tuning DNA repair in breast cancer cells. Cancer Research. PMID 27302171 DOI: 10.1158/0008-5472.Can-16-0774 |
0.336 |
|
| 2016 |
Elnahal SM, Blackford A, Smith K, Souranis AN, Briner V, McNutt TR, DeWeese TL, Wright JL, Terezakis SA. Identifying Predictive Factors for Incident Reports in Patients Receiving Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 94: 993-9. PMID 27026305 DOI: 10.1016/J.Ijrobp.2015.11.041 |
0.311 |
|
| 2016 |
Narang AK, Gergis C, Robertson SP, He P, Ram AN, McNutt TR, Griffith E, DeWeese TA, Honig S, Singh H, Song DY, Tran PT, DeWeese TL. Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation. International Journal of Radiation Oncology, Biology, Physics. 94: 254-62. PMID 26853334 DOI: 10.1016/J.Ijrobp.2015.10.056 |
0.493 |
|
| 2016 |
Hedayati M, Haffner MC, Coulter J, Raval RR, Zhang Y, Zhou H, Mian O, Knight EJ, Dalrymple S, Isaacs JT, Santos A, Hales RK, Razavi N, Nelson WG, Yegnasubramanian S, ... DeWeese TL, et al. Androgen deprivation followed by acute androgen stimulation selectively sensitizes AR-positive prostate cancer cells to ionizing radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26831716 DOI: 10.1158/1078-0432.Ccr-15-1147 |
0.846 |
|
| 2016 |
Mian OY, Robertson SP, Narang A, Aggarwal S, Bae HJ, Gergis C, McNutt TR, Tran PT, DeWeese TL, Song D. Dosimetric predictors of sexual function decline following LDR brachytherapy for prostate cancer (PCa). Journal of Clinical Oncology. 34: 113-113. DOI: 10.1200/Jco.2016.34.2_Suppl.113 |
0.4 |
|
| 2016 |
Hamstra DA, Mariados NF, Shah DK, Kurtzman SM, Sylvester JE, Zimberg SH, Hudes RS, Karsh L, Logsdon MD, Beyer DC, Kos M, Hsi RA, Forsythe K, Soffen EM, Francke PM, ... ... DeWeese TL, et al. Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial International Journal of Radiation Oncology Biology Physics. 96: 939. DOI: 10.1016/J.Ijrobp.2016.09.050 |
0.435 |
|
| 2016 |
Narang AK, Gergis C, Robertson SP, He P, Ram AN, McNutt TR, Griffith E, Deweese TA, Honig S, Singh H, Song DY, Tran PT, DeWeese TL. Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation International Journal of Radiation Oncology Biology Physics. 94: 254-262. DOI: 10.1016/j.ijrobp.2015.10.056 |
0.428 |
|
| 2016 |
Bae HJ, Mian O, Le Y, DeWeese T, Song D. Prostate Volume Reduction Prior to Brachytherapy Using 5-alpha Reductase Inhibition Alone without Androgen Blockade Brachytherapy. 15. DOI: 10.1016/J.Brachy.2016.04.324 |
0.365 |
|
| 2016 |
Kumar R, Le Y, Deweese T, Song DY. Re-implantation following suboptimal dosimetry in low-dose-rate prostate brachytherapy: technique for outpatient source insertion using local anesthesia Journal of Radiation Oncology. 5: 103-108. DOI: 10.1007/S13566-015-0198-3 |
0.345 |
|
| 2015 |
Rudra A, Hou D, Zhang Y, Coulter J, Zhou H, DeWeese TL, Greenberg MM. Bromopyridone Nucleotide Analogues, Anoxic Selective Radiosensitizing Agents That Are Incorporated in DNA by Polymerases. The Journal of Organic Chemistry. 80: 10675-85. PMID 26509218 DOI: 10.1021/Acs.Joc.5B01833 |
0.753 |
|
| 2015 |
Olson AC, Coleman CN, Hahn SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S. A Roadmap for a New Academic Pathway for Global Radiation Oncology. International Journal of Radiation Oncology, Biology, Physics. 93: 493-6. PMID 26460990 DOI: 10.1016/J.Ijrobp.2015.06.023 |
0.317 |
|
| 2015 |
Mian OY, Khattab MH, Hedayati M, Coulter J, Abubaker-Sharif B, Schwaninger JM, Veeraswamy RK, Brooks JD, Hopkins L, Shinohara DB, Cornblatt B, Nelson WG, Yegnasubramanian S, DeWeese TL. GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress. The Prostate. PMID 26447830 DOI: 10.1002/Pros.23111 |
0.83 |
|
| 2015 |
Ni X, Zhang Y, Zennami K, Castanares M, Mukherjee A, Raval RR, Zhou H, DeWEese TL, Lupold SE. Systemic administration and targeted radiosensitization via chemically synthetic aptamer-siRNA chimeras in human tumor xenografts. Molecular Cancer Therapeutics. PMID 26438155 DOI: 10.1158/1535-7163.Mct-15-0291-T |
0.495 |
|
| 2015 |
Sharabi AB, Lim M, DeWeese TL, Drake CG. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy. The Lancet. Oncology. 16: e498-509. PMID 26433823 DOI: 10.1016/S1470-2045(15)00007-8 |
0.409 |
|
| 2015 |
Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, ... ... DeWeese T, et al. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 92: 971-7. PMID 26054865 DOI: 10.1016/J.Ijrobp.2015.04.030 |
0.482 |
|
| 2015 |
Hatano K, Kumar B, Zhang Y, Coulter JB, Hedayati M, Mears B, Ni X, Kudrolli TA, Chowdhury WH, Rodriguez R, DeWeese TL, Lupold SE. A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation. Nucleic Acids Research. 43: 4075-86. PMID 25845598 DOI: 10.1093/Nar/Gkv273 |
0.694 |
|
| 2015 |
Attaluri A, Kandala SK, Wabler M, Zhou H, Cornejo C, Armour M, Hedayati M, Zhang Y, DeWeese TL, Herman C, Ivkov R. Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancer. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 31: 359-74. PMID 25811736 DOI: 10.3109/02656736.2015.1005178 |
0.496 |
|
| 2015 |
Sharabi AB, Nirschl CJ, Kochel CM, Nirschl TR, Francica BJ, Velarde E, Deweese TL, Drake CG. Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunology Research. 3: 345-55. PMID 25527358 DOI: 10.1158/2326-6066.Cir-14-0196 |
0.3 |
|
| 2015 |
Tran PT, Narang A, Ram A, Robertson SP, He P, Griffith E, Singh H, DeWeese T, Honig S, McNutt TR, Song D, DeWeese TL. End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation for prostate cancer. Journal of Clinical Oncology. 33: 68-68. DOI: 10.1200/Jco.2015.33.7_Suppl.68 |
0.524 |
|
| 2015 |
Coulter J, Haffner M, Mian O, Hedayati M, Zhang Y, Zhou H, Nelson W, Yegnasubramanian S, DeWeese T. Generation of DNA Double Strand Breaks in Prostate Cancer Cells by Androgen Receptor Antagonists, Hydroxyflutamide and Bicalutamide International Journal of Radiation Oncology*Biology*Physics. 93: S185. DOI: 10.1016/J.Ijrobp.2015.07.443 |
0.827 |
|
| 2015 |
Mian OY, Robertson SP, Narang A, Agarwal S, Bae HJ, McNutt TR, Tran PT, DeWeese TL, Song D. Dosimetric Predictors of Sexual Function Decline Following Low-Dose-Rate Brachytherapy for Prostate Cancer (PCa) International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.293 |
0.477 |
|
| 2015 |
Mian O, Haffner M, Coulter J, Esopi D, Meyers J, Gergis C, Assadi R, Nelson W, Yegnasubramanian S, DeWeese T. A Novel Technology for Noninvasive Detection of Prostate Cancer DNA in the Blood and Urine of Men With High-Risk PCA Receiving Radiation Therapy and Androgen Suppression International Journal of Radiation Oncology*Biology*Physics. 93: E226. DOI: 10.1016/J.Ijrobp.2015.07.1117 |
0.836 |
|
| 2015 |
Ellis RJ, Mariados NF, Sylvester JE, Shah DK, Karsh L, Hudes RS, Beyer DC, Kurtzman SM, Bogart JA, Hsi RA, Kos M, Logsdon MD, Zimberg SH, Forsythe K, Zhang H, ... ... DeWeese TL, et al. Prospective, Randomized, Patient-Blinded, Multicenter Trial of Perirectal Spacer in Men Undergoing Prostate IG-IMRT: Dosimetry and Toxicity Evaluation International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1040 |
0.444 |
|
| 2015 |
Elnahal SM, Mazur L, Blackford A, Judy G, Conley WK, Tracton G, McNutt TR, Chera BS, Marks LB, DeWeese TL, Wright JL, Terezakis SA. A Validated Nomogram to Predict Near Miss and Safety Incidents in Radiation Oncology: A Multi-institutional Effort International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.043 |
0.307 |
|
| 2015 |
Mian OY, Robertson SP, Narang A, Bae HJ, Tran P, DeWeese TL, Song D. A Retrospective Review of 366 Patients Treated With LDR Prostate Brachytherapy at a Single Institution: Histopathologic, Biochemical, and Dosimetric Predictors of Outcome Brachytherapy. 14. DOI: 10.1016/J.Brachy.2015.02.370 |
0.442 |
|
| 2014 |
Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, et al. The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. Frontiers in Oncology. 4: 333. PMID 25478326 DOI: 10.3389/Fonc.2014.00333 |
0.348 |
|
| 2014 |
Huynh-Le MP, Zhang Z, Tran PT, DeWeese TL, Song DY. Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists. International Journal of Radiation Oncology, Biology, Physics. 90: 1076-82. PMID 25442040 DOI: 10.1016/J.Ijrobp.2014.08.014 |
0.41 |
|
| 2014 |
Ellsworth SG, Alcorn SR, Hales RK, McNutt TR, DeWeese TL, Smith TJ. Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution. International Journal of Radiation Oncology, Biology, Physics. 89: 1100-5. PMID 25035214 DOI: 10.1016/J.Ijrobp.2014.04.028 |
0.329 |
|
| 2014 |
Freytag SO, Stricker H, Lu M, Elshaikh M, Aref I, Pradhan D, Levin K, Kim JH, Peabody J, Siddiqui F, Barton K, Pegg J, Zhang Y, Cheng J, Oja-Tebbe N, ... ... DeWeese T, et al. Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 89: 268-76. PMID 24837889 DOI: 10.1016/J.Ijrobp.2014.02.034 |
0.539 |
|
| 2014 |
Tuli R, Surmak AJ, Reyes J, Armour M, Hacker-Prietz A, Wong J, DeWeese TL, Herman JM. Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888. Translational Oncology. PMID 24836647 DOI: 10.1016/J.Tranon.2014.04.003 |
0.345 |
|
| 2014 |
Uhl M, Herfarth K, Eble MJ, Pinkawa M, van Triest B, Kalisvaart R, Weber DC, Miralbell R, Song DY, DeWeese TL. Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial. Radiation Oncology (London, England). 9: 96. PMID 24758224 DOI: 10.1186/1748-717X-9-96 |
0.474 |
|
| 2014 |
Regter S, Hedayati M, Zhang Y, Zhou H, Dalrymple S, Koch CJ, Isaacs JT, DeWeese TL. Androgen withdrawal fails to induce detectable tissue hypoxia in the rat prostate. The Prostate. 74: 805-10. PMID 24677180 DOI: 10.1002/Pros.22803 |
0.463 |
|
| 2014 |
Mukherjee A, Darlington T, Baldwin R, Holz C, Olson S, Kulkarni P, DeWeese TL, Getzenberg RH, Ivkov R, Lupold SE. Development and screening of a series of antibody-conjugated and silica-coated iron oxide nanoparticles for targeting the prostate-specific membrane antigen. Chemmedchem. 9: 1356-60. PMID 24591351 DOI: 10.1002/Cmdc.201300549 |
0.373 |
|
| 2014 |
Arian D, Hedayati M, Zhou H, Bilis Z, Chen K, DeWeese TL, Greenberg MM. Irreversible inhibition of DNA polymerase β by small-molecule mimics of a DNA lesion. Journal of the American Chemical Society. 136: 3176-83. PMID 24517090 DOI: 10.1021/Ja411733S |
0.322 |
|
| 2014 |
Sundi D, Cohen J, Cole A, Neuman B, Cooper J, Faisal F, Raben M, Song DY, Drake CG, Netto GJ, Macura K, DeWeese TL, Partin AW, Ross AE, Schaeffer EM. Multidisciplinary clinic evaluation changes prostate cancer stage and risk stratification. Journal of Clinical Oncology. 32: 91-91. DOI: 10.1200/Jco.2014.32.4_Suppl.91 |
0.494 |
|
| 2014 |
Sharabi A, Nirschl C, Ceccato T, Francica B, Alme A, Nirschl T, Velarde E, DeWeese T, Drake C. Abstract 635: Antigen-specific immune responses in melanoma using stereotactic radiotherapy combined with anti-PD1 checkpoint blockade Cancer Research. 74: 635-635. DOI: 10.1158/1538-7445.Am2014-635 |
0.318 |
|
| 2014 |
Pinkawa M, Eble M, Uhl M, Herfarth K, Van Triest B, Kalisvaart R, Weber D, Miralbell R, Song D, DeWeese T. OC-0159: Hydrogel spacer use for prostate cancer radiotherapy - 12 month toxicity and proctoscopy results Radiotherapy and Oncology. 111: S61. DOI: 10.1016/S0167-8140(15)30264-4 |
0.431 |
|
| 2014 |
Hatano K, Kumar B, Mears B, Chowdhury WH, Rodriguez R, Zhang Y, DeWeese TL, Lupold SE. MP24-12 FUNCTIONAL SCREENING IDENTIFIES MICRORNAS WHICH ALTER PROSTATE CANCER SENSITIVITY TO RADIATION THERAPY Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.293 |
0.519 |
|
| 2014 |
Sharabi A, Nirschl C, Ceccato T, Nirschl T, Francica B, Alme A, Velarde E, DeWeese T, Drake C. Role of Radiation Therapy in Inducing Antigen Specific Antitumor Immune Responses When Combined With Anti-PD1 Checkpoint Blockade: Mechanism and Clinical Implications International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.06.017 |
0.304 |
|
| 2014 |
Ivkov R, Attaluri A, Guiriba T, Liu Y, Zhou H, Hedayati M, DeWeese TL, Liapi E, Herman J. Magnetic Nanoparticle Hyperthermia and Radiation for Locally Advanced Pancreas Cancer: An In Vitro and In Vivo Study International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.681 |
0.36 |
|
| 2014 |
Abramowitz MC, Williams SG, Stephenson A, Kattan M, Pisansky TM, Klein EE, Anscher MS, Michalski J, Sandler HM, Forman JD, Zelefsky MJ, Kestin L, DeWeese TL, Liauw S, Valicenti RK, et al. Defining Long Term Failure Risk in Patients With an Undetectable PSA After Salvage Radiation International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.579 |
0.311 |
|
| 2014 |
Hedayati M, Hatano K, Kumar B, Chowdhury W, Rodriguez R, Zhang Y, DeWeese T, Lupold S. Functional Screening Identifies MicroRNAs That Alter Prostate Cancer Sensitivity to Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 90: S88-S89. DOI: 10.1016/J.Ijrobp.2014.05.482 |
0.424 |
|
| 2014 |
Khattab M, Raval R, Zhang Y, Regter S, Hedayati M, Banerjee S, Zhou H, Ferraris D, Alt J, Rojas C, Slusher B, Pomper M, DeWeese T. PSMA-Targeted Low Molecular Weight Urea-siRNA Conjugates for Targeted Knockdown of DNA-PK and Radiosensitization of Prostate Cancer Cell Lines International Journal of Radiation Oncology*Biology*Physics. 90: S798-S799. DOI: 10.1016/J.Ijrobp.2014.05.2306 |
0.457 |
|
| 2014 |
Elnahal SM, Blackford A, Ford EC, Souranis AN, Briner V, Smith K, McNutt TR, DeWeese TL, Terezakis SA. Identifying Predictive Factors for Treatment Variance Events in Patients Receiving Radiation Therapy: Comparative Results From a Comprehensive Safety Variance Database International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2177 |
0.321 |
|
| 2014 |
Alcorn SR, Saleemi S, Perng P, McNutt TR, Hales RK, DeWeese TL, Smith TJ, Ellsworth S. Analysis of Factors Complicating Treatment for Bone Metastases: Why Are Patients Not Receiving Single-Fraction Radiation Therapy? International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2045 |
0.319 |
|
| 2014 |
Robertson SP, Narang AK, Ram AN, He P, Griffith E, Singh H, DeWeese TA, Honig S, McNutt TR, Tran PT, DeWeese TL, Song DY. Prognostic and Therapeutic Implications of PNI in Prostate Cancer Patients Undergoing Definitive Radiation International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1437 |
0.395 |
|
| 2014 |
Ram AN, Robertson SP, Narang AK, Hei P, Griffith E, Singh H, DeWeese TA, Honig S, McNutt TR, DeWeese TL, Song DY, Tran PT. Prognostic Value of PSA Nadir in Patients Undergoing Definitive Radiation for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1426 |
0.463 |
|
| 2014 |
Narang A, Ram AN, Robertson SP, He P, Griffith E, Singh H, DeWeese T, Honig S, McNutt TR, Song D, Tran PT, DeWeese TL. End of Treatment PSA as a Novel Prognostic Factor in Patients Undergoing Definitive Radiation for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1422 |
0.418 |
|
| 2014 |
Ram A, Narang A, Robertson S, He P, Sundi D, Griffith E, Singh H, DeWeese T, Honig S, McNutt T, Schaeffer E, Ross A, Bivalacqua T, Partin A, Song D, ... ... DeWeese T, et al. Multiple Intermediate-Risk Factors as a Prognostic Tool for Men With Localized Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S454. DOI: 10.1016/J.Ijrobp.2014.05.1421 |
0.41 |
|
| 2014 |
Huynh-Le M, Zhang Z, Tran PT, DeWeese TL, Song DY. Discrepancies in Toxicity Grading of Rectal Bleeding: A Survey of Radiation Oncologists Who Treat Prostate Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1285 |
0.563 |
|
| 2013 |
Herfarth K, Uhl M, Eble MJ, Pinkawa M, Van Triest B, Kalisvaart R, Weber DC, Miralbell R, DeWeese TL, Ford E. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during IMRT for prostate cancer: Analysis of dosimetric outcomes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 35. PMID 28136986 DOI: 10.1200/Jco.2013.31.6_Suppl.35 |
0.513 |
|
| 2013 |
Wada S, Harris TJ, Tryggestad E, Yoshimura K, Zeng J, Yen HR, Getnet D, Grosso JF, Bruno TC, De Marzo AM, Netto GJ, Pardoll DM, DeWeese TL, Wong J, Drake CG. Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model. International Journal of Radiation Oncology, Biology, Physics. 87: 769-76. PMID 24064321 DOI: 10.1016/J.Ijrobp.2013.07.015 |
0.557 |
|
| 2013 |
Song H, Hedayati M, Hobbs RF, Shao C, Bruchertseifer F, Morgenstern A, Deweese TL, Sgouros G. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody. Molecular Cancer Therapeutics. 12: 2043-54. PMID 23873849 DOI: 10.1158/1535-7163.Mct-13-0108 |
0.325 |
|
| 2013 |
Alcorn S, Walker AJ, Gandhi N, Narang A, Wild AT, Hales RK, Herman JM, Song DY, Deweese TL, Antonarakis ES, Tran PT. Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer. International Journal of Molecular Sciences. 14: 14800-32. PMID 23863691 DOI: 10.3390/Ijms140714800 |
0.478 |
|
| 2013 |
Johnson TJ, Höti N, Liu C, Chowdhury WH, Li Y, Zhang Y, Lupold SE, Deweese T, Rodriguez R. Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer. Cancer Gene Therapy. 20: 394-402. PMID 23764901 DOI: 10.1038/Cgt.2013.34 |
0.484 |
|
| 2013 |
Christodouleas JP, Tang S, Susil RC, McNutt TR, Song DY, Bekelman J, Deville C, Vapiwala N, Deweese TL, Lu HM, Both S. The effect of anterior proton beams in the setting of a prostate-rectum spacer. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 38: 315-9. PMID 23578497 DOI: 10.1016/J.Meddos.2013.03.002 |
0.348 |
|
| 2013 |
González-Roibón N, Han JS, Lee S, Feng Z, Arslankoz S, Smith N, Pierorazio PM, Humphreys E, Deweese TL, Partin AW, Bivalacqua TJ, Han M, Trock B, Netto GJ. Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer. International Journal of Surgical Pathology. 21: 352-7. PMID 23564700 DOI: 10.1177/1066896913482729 |
0.403 |
|
| 2013 |
Song DY, Herfarth KK, Uhl M, Eble MJ, Pinkawa M, van Triest B, Kalisvaart R, Weber DC, Miralbell R, Deweese TL, Ford EC. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. International Journal of Radiation Oncology, Biology, Physics. 87: 81-7. PMID 23414766 DOI: 10.1016/J.Ijrobp.2012.12.019 |
0.534 |
|
| 2013 |
Gandhi N, Wild AT, Chettiar ST, Aziz K, Kato Y, Gajula RP, Williams RD, Cades JA, Annadanam A, Song D, Zhang Y, Hales RK, Herman JM, Armour E, DeWeese TL, et al. Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells. Cancer Biology & Therapy. 14: 347-56. PMID 23358469 DOI: 10.4161/cbt.23626 |
0.524 |
|
| 2013 |
Kachhap SK, Rosmus N, Collis SJ, Kortenhorst MSQ, Wissing MD, Hedayati M, Shabbeer S, Mendonca J, Deangelis J, Marchionni L, Lin J, Höti N, Nortier JWR, DeWeese TL, Hammers H, et al. Repair protein in prostate cancer cells treated with VPA. Plos One. DOI: 10.1371/Journal.Pone.0011208.G004 |
0.521 |
|
| 2013 |
peabody j, Freytag S, Stricker H, Elshaikh M, Lu M, Gupta N, Lane Z, DeWeese T, Rodriguez R, Movsas B. 1504 Randomized, Controlled, Phase 2 Trial Of Oncolytic Adenovirus-Mediated Suicide Gene Therapy Plus Imrt Versus Imrt Alone In Newly Diagnosed, Intermediate-Risk Prostate Cancer The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2983 |
0.456 |
|
| 2013 |
Raval R, Ni X, Zhang Y, Zhou H, Meeker A, Lupold S, DeWeese T. Systemic Delivery of Synthesized Aptamer-siRNA Chimeras Results in Prostate-Targeted Radiosensitization International Journal of Radiation Oncology*Biology*Physics. 87: S139. DOI: 10.1016/J.Ijrobp.2013.06.358 |
0.611 |
|
| 2013 |
Harris T, Wada S, Tryggestad E, Netto G, Wong J, Drake C, DeWeese T. Tumor Vaccination Combined With Radiation Therapy Mitigates Development and Progression of Metastatic Prostate Cancer: Studies in an Autochthonous Murine Prostate Cancer Model International Journal of Radiation Oncology*Biology*Physics. 87: S109. DOI: 10.1016/J.Ijrobp.2013.06.282 |
0.548 |
|
| 2013 |
Hedayati M, Arian D, Zhou H, Bilis Z, Chen K, Greenberg M, DeWeese T. Evaluation of Novel DNA Polymerase Beta Inhibitors as Potential Radiosensitizers of Prostate Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 87: S656. DOI: 10.1016/J.Ijrobp.2013.06.1738 |
0.482 |
|
| 2013 |
Alcorn S, Hales R, Smith T, McNutt T, Cheng M, Dy S, DeWeese T, Ellsworth S. Patterns of Fractionation of Palliative Radiation Therapy: A Single-Institution Experience International Journal of Radiation Oncology*Biology*Physics. 87: S562. DOI: 10.1016/J.Ijrobp.2013.06.1490 |
0.324 |
|
| 2012 |
Qiu H, Herman JM, Ahuja N, DeWeese TL, Song DY. Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer. Practical Radiation Oncology. 2: e77-e84. PMID 24674189 DOI: 10.1016/J.Prro.2011.11.001 |
0.535 |
|
| 2012 |
Tuli R, Surmak A, Reyes J, Hacker-Prietz A, Armour M, Leubner A, Blackford A, Tryggestad E, Jaffee EM, Wong J, Deweese TL, Herman JM. Development of a novel preclinical pancreatic cancer research model: bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenografts. Translational Oncology. 5: 77-84. PMID 22496923 DOI: 10.1593/Tlo.11316 |
0.332 |
|
| 2012 |
Lim Y, Hedayati M, Merchant AA, Zhang Y, Yu HH, Kastan MB, Matsui W, Deweese TL. Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation. International Journal of Radiation Oncology, Biology, Physics. 84: 800-6. PMID 22445004 DOI: 10.1016/J.Ijrobp.2012.01.026 |
0.333 |
|
| 2012 |
Tran PT, Hales RK, Zeng J, Aziz K, Salih T, Gajula RP, Chettiar S, Gandhi N, Wild AT, Kumar R, Herman JM, Song DY, DeWeese TL. Tissue biomarkers for prostate cancer radiation therapy. Current Molecular Medicine. 12: 772-87. PMID 22292443 DOI: 10.2174/156652412800792589 |
0.509 |
|
| 2012 |
Chaux A, Fajardo DA, Gonzalez-Roibon N, Partin AW, Eisenberger M, DeWeese TL, Netto GJ. High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy. Urology. 79: 863-8. PMID 22173174 DOI: 10.1016/J.Urology.2011.10.012 |
0.49 |
|
| 2012 |
Dalrymple SL, Becker RE, Zhou H, DeWeese TL, Isaacs JT. Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts. The Prostate. 72: 638-48. PMID 21837778 DOI: 10.1002/Pros.21467 |
0.562 |
|
| 2012 |
Brait M, Soudry E, Uemura M, Michailidi C, Califano JA, Zhang Y, DeWeese TL, Sidransky D. Abstract 4095: Stimulation of blood based biomarker release in primary tumor models of the head and neck Cancer Research. 72: 4095-4095. DOI: 10.1158/1538-7445.Am2012-4095 |
0.328 |
|
| 2012 |
Qiu H, Herman JM, Ahuja N, DeWeese TL, Song DY. Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer Practical Radiation Oncology. 2: e77-e84. DOI: 10.1016/j.prro.2011.11.001 |
0.466 |
|
| 2012 |
Hedayati M, Zhang Y, Zhou H, Knight E, Wabler M, Haffner M, Yegnasubramanian S, DeWeese T. Exploiting Androgen-induced DNA Double-strand Breaks: Optimally Sequencing Androgen Suppression and Radiation for the Treatment of Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S164. DOI: 10.1016/J.Ijrobp.2012.07.424 |
0.7 |
|
| 2011 |
Kumar R, Kang J, Herman JM, Tuli R, Pawlik TM, Tryggestad E, Smith K, DeWeese TL, Wong J, Ford EC. Stereotactic radiation treatment planning with volumetric modulated arc therapy: Impact of duodenal sparing on pancreatic tumor coverage. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 301. PMID 27985815 DOI: 10.1200/Jco.2011.29.4_Suppl.301 |
0.348 |
|
| 2011 |
Tuli R, Surmak A, Ford EC, Tryggestad E, Wong J, DeWeese TL, Herman JM. Bioluminescence image-guided irradiation and tumor monitoring in a preclinical pancreatic cancer mouse model. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 192. PMID 27985353 DOI: 10.1200/Jco.2011.29.4_Suppl.192 |
0.372 |
|
| 2011 |
Salih T, Aziz K, Thiyagarajan S, Armour M, Shanmugam B, Zeng J, Adam SJ, Felsher DW, DeWeese TL, Tran PT. Radiosensitization of MYC-overexpressing prostate cancer cells by statins. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 26. PMID 27968389 DOI: 10.1200/Jco.2011.29.7_Suppl.26 |
0.55 |
|
| 2011 |
Terezakis SA, Pronovost P, Harris K, Deweese T, Ford E. Safety strategies in an academic radiation oncology department and recommendations for action. Joint Commission Journal On Quality and Patient Safety / Joint Commission Resources. 37: 291-9. PMID 21819027 DOI: 10.1016/S1553-7250(11)37037-7 |
0.337 |
|
| 2011 |
Ni X, Zhang Y, Ribas J, Chowdhury WH, Castanares M, Zhang Z, Laiho M, DeWeese TL, Lupold SE. Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. The Journal of Clinical Investigation. 121: 2383-90. PMID 21555850 DOI: 10.1172/Jci45109 |
0.504 |
|
| 2011 |
Tuli R, Surmak A, Blackford A, Leubner A, Jaffee EM, DeWeese TL, Herman JM. Effect of inhibition of poly-(ADP ribose) polymerase on gemcitabine and radiation-induced cytotoxicity of pancreatic cancer cells. Journal of Clinical Oncology. 29: 203-203. DOI: 10.1200/Jco.2011.29.4_Suppl.203 |
0.384 |
|
| 2011 |
Ni X, Zhang Y, Ribas J, Chodhury WH, Castanares M, Zhang Z, Laiho M, DeWeese TL, Lupold SE. Abstract 5387: Prostate-targeted radiosensitization via aptamer-shRNA chimeras Cancer Research. 71: 5387-5387. DOI: 10.1158/1538-7445.Am2011-5387 |
0.533 |
|
| 2011 |
Nemkov V, Ruffini R, Goldstein R, Jackowski J, DeWeese TL, Ivkov R. Magnetic field generating inductor for cancer hyperthermia research Compel-the International Journal For Computation and Mathematics in Electrical and Electronic Engineering. 30: 1626-1636. DOI: 10.1108/03321641111152784 |
0.341 |
|
| 2011 |
Song D, Herfarth K, Uhl M, Triest Bv, Kalisvaart R, Eble M, Pinkawa M, Weber D, Miralbell R, DeWeese T. A Multi-institutional Trial Of Rectal Dose Reduction During Prostate Radiotherapy Via Polyethylene-glycol Hydrogel Injection: Initial Results International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.670 |
0.46 |
|
| 2011 |
DeWeese TL, Lim Y, Hedayati M, Merchant A, Zhang Y, Yu HM, Kastan MB, Matsui W. Chloroquine Activates ATM and Improves Hematopoietic Recovery and Survival of Mice following Low Dose-rate Radiation International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.343 |
0.309 |
|
| 2011 |
Aziz K, Salih T, Thiyagarajan S, Armour M, Zeng J, Gajula R, Chettair S, Hales R, DeWeese T, Tran PT. Statins Radiosensitize Myc Over-expressing Prostate Cancer Cells International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.113 |
0.522 |
|
| 2010 |
Kachhap SK, Rosmus N, Collis SJ, Kortenhorst MS, Wissing MD, Hedayati M, Shabbeer S, Mendonca J, Deangelis J, Marchionni L, Lin J, Höti N, Nortier JW, DeWeese TL, Hammers H, et al. Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor. Plos One. 5: e11208. PMID 20585447 DOI: 10.1371/Journal.Pone.0011208 |
0.345 |
|
| 2010 |
Liu C, Zhang Y, Liu MM, Zhou H, Chowdhury W, Lupold SE, Deweese TL, Rodriguez R. Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer. International Journal of Radiation Biology. 86: 220-9. PMID 20201650 DOI: 10.3109/09553000903419338 |
0.353 |
|
| 2010 |
Susil RC, McNutt TR, DeWeese TL, Song D. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 76: 1251-8. PMID 19939577 DOI: 10.1016/J.Ijrobp.2009.07.1679 |
0.511 |
|
| 2010 |
Lim Y, Hedayati M, Merchant A, Zhang Y, DeWeese T, Matsui W. Improved Survival and Recovery of Hematopoiesis Following Lethal Radiation by Chloroquine-Mediated Activation of ATM Blood. 116: 2228-2228. DOI: 10.1182/Blood.V116.21.2228.2228 |
0.356 |
|
| 2010 |
Ivkov R, Armour M, Cornejo C, Zhou H, Hedayati M, Zhang Y, DeWeese T. Abstract 5524: Radiosensitization of nanoparticle-based thermal delivery in mice bearing human prostate cancer Cancer Research. 70: 5524-5524. DOI: 10.1158/1538-7445.Am10-5524 |
0.35 |
|
| 2010 |
Ni X, Zhang Y, Ribas J, DeWeese TL, Lupold SE. Abstract 1503: PSMA Aptamer-targeted siRNAs selectively Eehance prostate cancer radiation sensitivity Cancer Research. 70: 1503-1503. DOI: 10.1158/1538-7445.Am10-1503 |
0.553 |
|
| 2010 |
Fajardo D, Partin A, Eisenberger M, DeWeese T, Netto G. 1560 Isolated Single Core High Grade Prostatic Adenocarcinoma Is Associated With Increased Risk For Extraprostatic Extension, Seminal Vesicle Invasion And Positive Margin Status On Radical Prostatectomy The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1325 |
0.41 |
|
| 2010 |
Christodouleas JP, Susil RC, McNutt TR, Song DY, DeWeese TL, Bekelman J, Vapiwala N, Shinkle B, Lu H, Both S. The Impact of a Rectal-Prostate Spacer on Proton Radiation of the Prostate: A Planning Study International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.335 |
0.52 |
|
| 2010 |
Lin S, Zhou H, Kumar R, Herman J, DeWeese T, Iacobuzio-Donahue C, Baylin S. Reprimo-like is a P53 Responsive Gene Whose Promoter Methylation May Predict for Radiation Responsiveness in Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S129. DOI: 10.1016/J.Ijrobp.2010.07.325 |
0.329 |
|
| 2010 |
DeWeese T, Ni X, Zhang Y, Hedayati M, Lupold S. Substantial Increases in Prostate Cancer Tumor Control Result from a Combination of PSMA Aptamer-targeted siRNAs and Radiation International Journal of Radiation Oncology*Biology*Physics. 78: S113-S114. DOI: 10.1016/J.Ijrobp.2010.07.290 |
0.527 |
|
| 2010 |
Hales R, Santos A, Vander Griend D, Zhang Y, Hedayati M, Isaacs J, DeWeese T. In Vivo Analysis of Androgens and Radiation Timing in Prostate Cancer Growth International Journal of Radiation Oncology*Biology*Physics. 78: S112. DOI: 10.1016/J.Ijrobp.2010.07.286 |
0.545 |
|
| 2010 |
Herman J, Kang J, Tuli R, Wolfgang C, Pawlik T, Tryggestad E, Smith K, DeWeese T, Wong J, Ford E. Stereotactic Radiation Treatment Planning with Volumetric Modulated Arc Therapy (VMAT): Impact of Duodenal Sparing International Journal of Radiation Oncology*Biology*Physics. 78: S790-S791. DOI: 10.1016/J.Ijrobp.2010.07.1831 |
0.325 |
|
| 2010 |
Tuli R, Surmak A, Blackford A, Reyes J, Leubner A, Zhang Y, Zhou H, Jaffee E, DeWeese T, Herman J. Poly (ADP Ribose) Polymerase Inhibition with ABT-888 Alone and in Combination with Gemcitabine Enhances Radiosensitization of Pancreatic Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 78: S653-S654. DOI: 10.1016/J.Ijrobp.2010.07.1521 |
0.348 |
|
| 2010 |
Surmak A, Tuli R, Reyes J, Armour M, Purger D, Ford E, Tryggestad E, Wong J, DeWeese T, Herman J. Bioluminescence Imaging for Orthotopic Tumor Monitoring and Image Guided Radiation in a Preclinical Pancreas Cancer Mouse Model International Journal of Radiation Oncology*Biology*Physics. 78: S640. DOI: 10.1016/J.Ijrobp.2010.07.1491 |
0.338 |
|
| 2010 |
Ford EC, Terezakis S, Pronovost P, Myers L, Bell R, Wong J, Song D, Zellars R, DeWeese T. Patient Safety in Radiation Oncology: Tools for Improvement International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.1326 |
0.314 |
|
| 2009 |
Lin J, Sinibaldi VJ, Carducci MA, Denmeade S, Song D, Deweese T, Eisenberger MA. Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer. Urologic Oncology. 29: 670-5. PMID 19962920 DOI: 10.1016/J.Urolonc.2009.10.003 |
0.481 |
|
| 2009 |
Sharma P, Wisniewski A, Braga-Basaria M, Xu X, Yep M, Denmeade S, Dobs AS, DeWeese T, Carducci M, Basaria S. Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. The Journal of Urology. 182: 2265-72. PMID 19758646 DOI: 10.1016/J.Juro.2009.07.030 |
0.494 |
|
| 2009 |
Antonarakis ES, Heath EI, Walczak JR, Nelson WG, Fedor H, De Marzo AM, Zahurak ML, Piantadosi S, Dannenberg AJ, Gurganus RT, Baker SD, Parnes HL, DeWeese TL, Partin AW, Carducci MA. Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men with Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers Journal of Clinical Oncology. 27: 4986-4993. PMID 19720908 DOI: 10.1200/Jco.2009.21.9410 |
0.558 |
|
| 2009 |
Hales RK, Richardson ML, Hristov B, Drew R, Yahner T, Demski R, Nyberg D, DeWeese TL. A Pilot Study to Improve Workflow in an Academic Radiation Oncology Department International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.326 |
0.335 |
|
| 2009 |
DeWeese T, Ni X, Zhang Y, Lupold S. PSMA Aptamer-targeted SiRNAs Selectively Enhance Prostate Cancer Radiation Sensitivity International Journal of Radiation Oncology*Biology*Physics. 75: S91-S92. DOI: 10.1016/J.Ijrobp.2009.07.225 |
0.532 |
|
| 2009 |
Hirani ZA, Ivkov R, Zhang Y, Armour M, Hedayati MA, Ford EC, DeWeese TL, Herman JM. Evaluation of Hypofractionated Radiation Therapy (HRT) and Magnetic Nanoparticle Heating for Pancreatic Cancer International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1283 |
0.346 |
|
| 2008 |
Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry RA, Morgan J, Hicks J, DeWeese TL, Isaacs WB, Bova GS, De Marzo AM, Nelson WG. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Research. 68: 8954-67. PMID 18974140 DOI: 10.1158/0008-5472.Can-07-6088 |
0.75 |
|
| 2008 |
Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, ... ... DeWeese TL, et al. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology. 72: 1298-302; discussion. PMID 18672274 DOI: 10.1016/J.Urology.2008.05.057 |
0.434 |
|
| 2008 |
Harris TJ, Hipkiss EL, Borzillary S, Wada S, Grosso JF, Yen HR, Getnet D, Bruno TC, Goldberg MV, Pardoll DM, DeWeese TL, Drake CG. Radiotherapy augments the immune response to prostate cancer in a time-dependent manner. The Prostate. 68: 1319-29. PMID 18561247 DOI: 10.1002/Pros.20794 |
0.47 |
|
| 2008 |
Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. Jama. 299: 2760-9. PMID 18560003 DOI: 10.1001/Jama.299.23.2760 |
0.48 |
|
| 2008 |
Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC. Prostate Cancer-Specific Survival Following Salvage Radiotherapy Vs. Observation In Men With Biochemical Recurrence After Radical Prostatectomy The Journal of Urology. 179: 491-492. DOI: 10.1016/S0022-5347(08)61447-0 |
0.503 |
|
| 2008 |
Harris T, Wada S, Yen H, Wong J, Pardoll D, Drake C, DeWeese T. Adjuvant Vaccine Therapy in Combination with Radiation for Treatment of Prostate Cancer: Preclinical Validation in a Mouse Model of Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 72: S63. DOI: 10.1016/J.Ijrobp.2008.06.907 |
0.543 |
|
| 2008 |
Lin S, Tsai H, Vescovi A, Laterra J, DeWeese T, Baylin S. The Efficacy of Low Dose Epigenetic Agents in Combination with Ionizing Radiation in a Neurosphere Tumor Model of Glioblastoma Multiforme International Journal of Radiation Oncology*Biology*Physics. 72: S708. DOI: 10.1016/J.Ijrobp.2008.06.537 |
0.317 |
|
| 2008 |
Christodouleas J, Yeater D, Jabbour S, Mangold L, Leman E, Drew R, Humphreys E, Partin A, Getzenberg R, DeWeese T. Modulation of EPCA-2 Levels in Men with Localized Prostate Cancer Treated with Radiation with or without Androgen Suppression Therapy International Journal of Radiation Oncology*Biology*Physics. 72: S316. DOI: 10.1016/J.Ijrobp.2008.06.1091 |
0.544 |
|
| 2008 |
Trock BJ, DeWeese TL. Adjuvant radiotherapy after surgery for prostate cancer - Reply Jama - Journal of the American Medical Association. 300: 2119. DOI: 10.1001/Jama.2008.563 |
0.497 |
|
| 2007 |
Walsh PC, DeWeese TL, Eisenberger MA. Clinical practice. Localized prostate cancer. The New England Journal of Medicine. 357: 2696-705. PMID 18160689 DOI: 10.1056/Nejmcp0706784 |
0.507 |
|
| 2007 |
Swartz MJ, Janson K, Deweese TL, Song DY. Radiation therapy for prostate cancer: the role for dose escalation. Comprehensive Therapy. 33: 216-22. PMID 18025613 DOI: 10.1007/S12019-007-8014-7 |
0.537 |
|
| 2007 |
Yu HH, Song DY, Tsai YY, Thompson T, Frassica DA, DeWeese TL. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy. Urology. 70: 111-6. PMID 17656219 DOI: 10.1016/J.Urology.2007.03.020 |
0.468 |
|
| 2007 |
Song DY, DeWeese TL. Defining the appropriate measure of success for adjuvant radiation following prostatectomy. Nature Clinical Practice. Urology. 4: 416-7. PMID 17549086 DOI: 10.1038/Ncpuro0834 |
0.358 |
|
| 2007 |
Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, ... DeWeese TL, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2035-41. PMID 17513807 DOI: 10.1200/Jco.2006.08.9607 |
0.506 |
|
| 2007 |
Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, DeWeese TL, Sandler HM. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 68: 1417-23. PMID 17418972 DOI: 10.1016/J.Ijrobp.2007.01.049 |
0.492 |
|
| 2007 |
Bajaj GK, Zhang Z, Garrett-Mayer E, Drew R, Sinibaldi V, Pili R, Denmeade SR, Carducci MA, Eisenberger MA, DeWeese TL. Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy. Urology. 69: 526-31. PMID 17382158 DOI: 10.1016/J.Urology.2006.12.006 |
0.534 |
|
| 2007 |
Carducci MA, Walczak JR, Heath E, Nelson WG, DeMarzo AM, Zahurak M, Dannenberg AJ, Parnes H, DeWeese TL, Partin AW. A randomized, placebo-controlled trial of celecoxib in men prior to receiving prostatectomy for clinically localized adenocarcinoma of the prostate: Evaluation of drug-specific biomarker modulation Journal of Clinical Oncology. 25: 5001-5001. DOI: 10.1200/JCO.2007.25.18_SUPPL.5001 |
0.492 |
|
| 2007 |
Susil RC, Teslow TN, McNutt TR, Wong J, DeWeese TL, Song D. Characterization of Intrafraction Prostate Deformation and Displacement via Twice Daily MVCT Imaging International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1987 |
0.421 |
|
| 2007 |
Chiplis P, Mock V, Wenzel J, Stewart K, Griffith K, DeWeese T. Effects of Exercise on Bone Loss and Functional Capacity During Prostate Cancer Treatment International Journal of Radiation Oncology*Biology*Physics. 69: S321-S322. DOI: 10.1016/J.Ijrobp.2007.07.1386 |
0.422 |
|
| 2006 |
Song DY, DeWeese TL. Can PSA nadir predict prostate cancer outcomes following radiotherapy? Nature Clinical Practice. Urology. 3: 464-5. PMID 16964182 DOI: 10.1038/Ncpuro0564 |
0.507 |
|
| 2006 |
Coffey DS, Getzenberg RH, DeWeese TL. Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect". Jama. 296: 445-8. PMID 16868303 DOI: 10.1001/Jama.296.4.445 |
0.372 |
|
| 2006 |
Stephenson AJ, Pollack A, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Kupelian PA, Anscher MS, Michalski JM, Sandler HM, Zelefsky MJ, Forman JD, Lin DW, Kestin LL, ... ... Deweese TL, et al. 1192: A Nomogram to Predict the Outcome of Salvage Radiotherapy (RT) for Biochemical Recurrence (BCR) Following Radical Prostatectomy (RP) Journal of Urology. 175: 384-384. DOI: 10.1016/S0022-5347(18)33417-7 |
0.308 |
|
| 2006 |
Yu HM, Song DY, Tsai Y, Thompson T, Frassica DA, DeWeese TL. 2189: Presence of Perineural Invasion on Biopsy Significantly Impacts Biochemical Control of Prostate Cancer Following Definitive External Beam Radiation Therapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.594 |
0.514 |
|
| 2006 |
Lin SH, Sugar E, Saleh H, Teslow T, McNutt T, DeWeese TL, Wong J, Song D. 2772 : Comparison of Daily Couch Shifts Using MVCT (TomoTherapy) and B-Mode Ultrasound (BAT System) During Prostate Radiotherapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.1189 |
0.429 |
|
| 2005 |
DeWeese TL, Song DY. Radiation dose escalation as treatment for clinically localized prostate cancer: is more really better? Jama. 294: 1274-6. PMID 16160137 DOI: 10.1001/Jama.294.10.1274 |
0.55 |
|
| 2005 |
Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Research. 65: 6773-9. PMID 16061659 DOI: 10.1158/0008-5472.Can-05-1948 |
0.606 |
|
| 2005 |
Rosenbaum E, Zahurak M, Sinibaldi V, Carducci MA, Pili R, Laufer M, DeWeese TL, Eisenberger MA. Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4437-43. PMID 15958628 DOI: 10.1158/1078-0432.Ccr-04-2252 |
0.502 |
|
| 2005 |
Collis SJ, DeWeese TL, Jeggo PA, Parker AR. The life and death of DNA-PK. Oncogene. 24: 949-61. PMID 15592499 DOI: 10.1038/Sj.Onc.1208332 |
0.304 |
|
| 2005 |
Bajaj GK, Garrett-Mayer E, Drew R, Sinibaldi VJ, Gaver M, Pili R, Denmeade S, Carducci MA, Eisenberger M, Deweese TL. A phase II study of imatinib mesylate in prostate cancer patients with evidence of biochemical relapse following definitive radical retropubic prostatectomy or radiation therapy Journal of Clinical Oncology. 23: 3092-3092. DOI: 10.1200/jco.2005.23.16_suppl.3092 |
0.429 |
|
| 2005 |
DeWeese TL, Zhang Y, Koch C, Dalrymple S, Isaacs J. Androgen Withdrawal Fails to Induce Detectable Tissue Hypoxia in the Prostate International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.794 |
0.457 |
|
| 2005 |
Bajaj G, Garret-Mayer E, Zhang Z, Drew R, Sinibaldi V, Gaver M, Pili R, Denmeade S, Carducci M, Nelson W, Eisenberger M, DeWeese T. A Phase II Study of Imatinib Mesylate in Prostate Cancer Patients With Evidence of Biochemical Relapse Following Definitive Radical Retropubic Prostatectomy or Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 63: S312. DOI: 10.1016/J.Ijrobp.2005.07.535 |
0.64 |
|
| 2004 |
Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer. The Journal of Urology. 172: S6-11; discussion S1. PMID 15535435 DOI: 10.1097/01.Ju.0000142058.99614.Ff |
0.644 |
|
| 2004 |
Collis SJ, Schwaninger JM, Ntambi AJ, Keller TW, Nelson WG, Dillehay LE, Deweese TL. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. The Journal of Biological Chemistry. 279: 49624-32. PMID 15377658 DOI: 10.1074/Jbc.M409600200 |
0.526 |
|
| 2004 |
DeWeese TL. Radiation therapy and androgen suppression as treatment for clinically localized prostate cancer: the new standard? Jama. 292: 864-866. PMID 15316002 DOI: 10.1001/Jama.292.7.864 |
0.54 |
|
| 2004 |
Collis SJ, Neutzel S, Thompson TL, Swartz MJ, Dillehay LE, Collector MI, Sharkis SJ, DeWeese TL. Hematopoietic progenitor stem cell homing in mice lethally irradiated with ionizing radiation at differing dose rates. Radiation Research. 162: 48-55. PMID 15222777 DOI: 10.1667/Rr3197 |
0.305 |
|
| 2004 |
Collis SJ, DeWeese TL. Enhanced radiation response through directed molecular targeting approaches. Cancer and Metastasis Reviews. 23: 277-292. PMID 15197329 DOI: 10.1023/B:Canc.0000031767.30730.D1 |
0.381 |
|
| 2004 |
De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI, Isaacs WB, Nelson WG. Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. Journal of Cellular Biochemistry. 91: 459-77. PMID 14755677 DOI: 10.1002/Jcb.10747 |
0.733 |
|
| 2004 |
Lapidus RG, Dang W, Rosen DM, Gady AM, Zabelinka Y, O'Meally R, DeWeese TL, Denmeade SR. Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation. The Prostate. 58: 291-8. PMID 14743469 DOI: 10.1002/Pros.10331 |
0.46 |
|
| 2004 |
Collis S, Schwaninger J, Ntambi A, Keller T, Dillehay L, Nelson W, DeWeese T. Low-level radiation-induced DNA damage evades early cellular response mechanisms leading to increased cell death International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.07.176 |
0.505 |
|
| 2004 |
Pollack A, Hanlon A, Pisansky T, Sandler H, Kuban D, Catton C, Michalski J, Zelefsky M, Kupelian P, Kestin L, Valicenti R, DeWeese T. A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy International Journal of Radiation Oncology*Biology*Physics. 60: S186-S187. DOI: 10.1016/J.Ijrobp.2004.06.120 |
0.32 |
|
| 2003 |
Hughes MA, Wang A, DeWeese TL. Two secondary malignancies after radiotherapy for seminoma: case report and review of the literature. Urology. 62: 748. PMID 14550463 DOI: 10.1016/S0090-4295(03)00669-1 |
0.471 |
|
| 2003 |
Parker AR, O'Meally RN, Sahin F, Su GH, Racke FK, Nelson WG, DeWeese TL, Eshleman JR. Defective human MutY phosphorylation exists in colorectal cancer cell lines with wild-type MutY alleles. The Journal of Biological Chemistry. 278: 47937-45. PMID 12966098 DOI: 10.1074/Jbc.M306598200 |
0.466 |
|
| 2003 |
Collis SJ, Khater K, DeWeese TL. Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy. World Journal of Urology. 21: 275-289. PMID 12920560 DOI: 10.1007/S00345-003-0363-Y |
0.488 |
|
| 2003 |
DeWeese TL, Nelson WG. Inadequate "caretaker" gene function and human cancer development. Methods in Molecular Biology (Clifton, N.J.). 222: 249-68. PMID 12710692 DOI: 10.1385/1-59259-328-3:249 |
0.485 |
|
| 2003 |
Collis SJ, Swartz MJ, Nelson WG, DeWeese TL. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Research. 63: 1550-4. PMID 12670903 |
0.461 |
|
| 2003 |
Collis SJ, Ketner GW, Hicks JL, Nelson WG, Demarzo AM, Deweese TL. Expression of the DNA-PK binding protein E4-34K fails to confer radiation sensitivity to mammalian cells International Journal of Radiation Biology. 79: 53-60. PMID 12556331 |
0.439 |
|
| 2003 |
Li S, Simons J, Detorie N, O'Rourke B, Hamper U, DeWeese TL. Dosimetric and technical considerations for interstitial adenoviral gene therapy as applied to prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 55: 204-14. PMID 12504055 DOI: 10.1016/S0360-3016(02)03862-2 |
0.507 |
|
| 2003 |
Collis SJ, Ketner GW, Hicks JL, Nelson WG, Demarzo AM, Deweese TL. Expression of the DNA-PK binding protein E4-34K fails to confer radiation sensitivity to mammalian cells. International Journal of Radiation Biology. 79: 53-60. DOI: 10.1080/713864983 |
0.505 |
|
| 2003 |
Collis S, Swartz M, DeWeese T. siRNA-silencing of DNA repair factors results in enhanced radiation and chemotherapy-mediated killing of human cancer cells International Journal of Radiation Oncology Biology Physics. 57. DOI: 10.1016/S0360-3016(03)00904-0 |
0.421 |
|
| 2002 |
Heath EI, DeWeese TL, Partin AW, De Marzo AM, Groopman JD, Nelson WG, Piantadosi SA, Lieberman R, Carducci MA. The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate. Clinical Prostate Cancer. 1: 182-7. PMID 15046694 DOI: 10.3816/Cgc.2002.N.021 |
0.551 |
|
| 2002 |
Parker AR, O'Meally RN, Oliver DH, Hua L, Nelson WG, DeWeese TL, Eshleman JR. 8-Hydroxyguanosine repair is defective in some microsatellite stable colorectal cancer cells. Cancer Research. 62: 7230-3. PMID 12499263 |
0.383 |
|
| 2002 |
Nelson WG, DeWeese TL, DeMarzo AM. The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Reviews. 21: 3-16. PMID 12400993 DOI: 10.1023/A:1020110718701 |
0.643 |
|
| 2002 |
Song DY, Thompson TL, Ramakrishnan V, Harrison R, Bhavsar N, Onaodowan O, DeWeese TL. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology. 60: 281-7. PMID 12137827 DOI: 10.1016/S0090-4295(02)01709-0 |
0.396 |
|
| 2002 |
Basaria S, Lieb J, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clinical Endocrinology. 56: 779-86. PMID 12072048 DOI: 10.1046/J.1365-2265.2002.01551.X |
0.41 |
|
| 2002 |
Fichtinger G, DeWeese TL, Patriciu A, Tanacs A, Mazilu D, Anderson JH, Masamune K, Taylor RH, Stoianovici D. System for robotically assisted prostate biopsy and therapy with intraoperative CT guidance. Academic Radiology. 9: 60-74. PMID 11918360 DOI: 10.1016/S1076-6332(03)80297-0 |
0.371 |
|
| 2002 |
Song DY, DeWeese TL. Results of Salvage Radiotherapy for Rising or Persistent PSA Following Radical Prostatectomy: P-28 Cancer Journal. 8: 503. DOI: 10.1097/00130404-200211000-00073 |
0.353 |
|
| 2002 |
Collis S, Tyszko S, Thompson T, Dillehay L, Collector M, Sharkis S, DeWeese T. Stem cell homing in mice lethally irradiated with differing dose rates of ionizing radiation International Journal of Radiation Oncology*Biology*Physics. 54: 219. DOI: 10.1016/S0360-3016(02)03436-3 |
0.309 |
|
| 2001 |
Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD, Kensler TW. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Annals of the New York Academy of Sciences. 952: 135-44. PMID 11795433 DOI: 10.1111/J.1749-6632.2001.Tb02734.X |
0.629 |
|
| 2001 |
Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, Van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, Deweese TL, De Marzo AM, et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells American Journal of Pathology. 159: 1815-1826. PMID 11696442 DOI: 10.1016/S0002-9440(10)63028-3 |
0.575 |
|
| 2001 |
Thurman SA, Ramakrishna NR, DeWeese TL. Radiation therapy for the treatment of locally advanced and metastatic prostate cancer. Hematology/Oncology Clinics of North America. 15: 423-43. PMID 11525289 DOI: 10.1016/S0889-8588(05)70224-0 |
0.463 |
|
| 2001 |
Walsh PC, Deweese TL, Eisenberger MA. A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment. The Journal of Urology. 166: 508-516. PMID 11458056 DOI: 10.1016/S0022-5347(05)65972-1 |
0.432 |
|
| 2001 |
Nelson WG, Demarzo AM, DeWeese T. The Molecular Pathogenesis of Prostate Cancer European Urology. 39: 8-11. PMID 11340278 DOI: 10.1159/000052574 |
0.639 |
|
| 2001 |
DeWeese TL, Hruszkewycz AM, Marnett LJ. Oxidative stress in chemoprevention trials. Urology. 57: 137-40. PMID 11295612 DOI: 10.1016/S0090-4295(00)00959-6 |
0.506 |
|
| 2001 |
Nelson WG, Marzo AMD, DeWeese TL. The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention Urology. 57: 39-45. PMID 11295593 DOI: 10.1016/S0090-4295(00)00939-0 |
0.649 |
|
| 2001 |
DeWeese TL, Chen Y, Scott S, Stephens J, Henderson D, Yu DC. Significant synergy exists between CV706, a PSA-selective, replication-competent adenovirus and radiation in the treatment of human prostate cancer International Journal of Radiation Oncology Biology Physics. 51: 115. DOI: 10.1016/S0360-3016(01)02034-X |
0.544 |
|
| 2000 |
Chan DY, Koniaris L, Magee C, Ferrell M, Solomon S, Lee BR, Anderson JH, Smith DO, Czapski J, Deweese T, Choti MA, Kavoussi LR. Feasibility of ablating normal renal parenchyma by interstitial photon radiation energy: study in a canine model. Journal of Endourology / Endourological Society. 14: 111-6. PMID 10772501 DOI: 10.1089/End.2000.14.111 |
0.3 |
|
| 2000 |
DeWeese TL, Song DY. Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate. Urology. 55: 169-174. PMID 10688072 DOI: 10.1016/S0090-4295(99)00419-7 |
0.512 |
|
| 2000 |
Hopkins LA, Shipman JM, Buckley NM, Zahurak ML, Sokoll LJ, Chan DW, Simons JW, Nelson WG, DeWeese TL. Basic fibroblastic growth factor in human prostate cancer: in vitro and human studies of radiation-induced modulation International Journal of Radiation Oncology Biology Physics. 48: 282-283. DOI: 10.1016/S0360-3016(00)80367-3 |
0.614 |
|
| 2000 |
DeWeese TL, Drew R, Li S, Goemann MA, Mikhak B, Rodriguez R, Hamper U, DeJong MR, Detorie N, Simons JW. Results of a phase I study of CN706, a replication-competent cytolytic adenovirus, for the treatment of adenocarcinoma of the prostate which is locally-recurrent following radiation therapy☆ International Journal of Radiation Oncology Biology Physics. 48: 172-173. DOI: 10.1016/S0360-3016(00)80138-8 |
0.484 |
|
| 1999 |
Hurwitz MD, DeWeese TL, Zinreich ES, Epstein JI, Partin AW. Nuclear morphometry predicts disease-free interval for clinically localized adenocarcinoma of the prostate treated with definitive radiation therapy. International Journal of Cancer. 84: 594-7. PMID 10567904 DOI: 10.1002/(Sici)1097-0215(19991222)84:6<594::Aid-Ijc9>3.0.Co;2-D |
0.486 |
|
| 1999 |
Carducci MA, DeWeese TL, Nelson JB. Prostate-specific antigen and other markers of therapeutic response. The Urologic Clinics of North America. 26: 291-302, viii. PMID 10361552 DOI: 10.1016/S0094-0143(05)70069-0 |
0.483 |
|
| 1999 |
Ramakrishna NR, Rioseco-Camacho N, Sawyers CL, Yu DC, Henderson D, Simons JW, DeWeese TL. Synergism Of Ionizing Radiation And Gene Therapy With The Replication Competent Cn706 Adenovirus In The Lapc-4 Prostate Cancer Cell Line The Journal of Urology. 62. DOI: 10.1097/00005392-199904010-00252 |
0.528 |
|
| 1999 |
DeWeese TL, Ramakrishna N, Demarzo A, Rodriguez R, Li S, Detorie N, Drew R, Goemann M, Mikhak B, Simons JW. 2152 Bioactivity of CN706, a PSA specific oncolytic adenoviral vector: A phase I trial of in vivo gene therapy for locally-recurrent prostate cancer following radiation therapy International Journal of Radiation Oncology Biology Physics. 45: 356. DOI: 10.1016/S0360-3016(99)90421-2 |
0.499 |
|
| 1999 |
Ramakrishna N, Rioseco-Camacho N, Sawyers C, Yu D, Henderson D, Simons J, DeWeese T. 2043 Mechanisms of therapeutic synergy between radiation treatment and adenoviral gene therapy with the replication competent PSA-specific vector CN706 in the LAPC-4 and LnCaP prostate cancer cell lines International Journal of Radiation Oncology*Biology*Physics. 45: 300. DOI: 10.1016/S0360-3016(99)90313-9 |
0.528 |
|
| 1998 |
DeWeese TL, Shipman JM, Larrier NA, Buckley NM, Kidd LR, Groopman JD, Cutler RG, te Riele H, Nelson WG. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proceedings of the National Academy of Sciences of the United States of America. 95: 11915-20. PMID 9751765 DOI: 10.1073/Pnas.95.20.11915 |
0.526 |
|
| 1998 |
Deweese TL, Shipman JM, Dillehay LE, Nelson WG. Sensitivity Of Human Prostatic Carcinoma Cell Lines To Low Dose Rate Radiation Exposure The Journal of Urology. 159: 591-598. PMID 9649298 DOI: 10.1016/S0022-5347(01)63990-9 |
0.595 |
|
| 1998 |
Healy CG, Simons JW, Carducci MA, DeWeese TL, Bartkowski M, Tong KP, Bolton WE. Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry. 32: 109-19. PMID 9627224 DOI: 10.1002/(Sici)1097-0320(19980601)32:2<109::Aid-Cyto6>3.0.Co;2-G |
0.327 |
|
| 1998 |
Cadeddu JA, Partin AW, DeWeese TL, Walsh PC. Long-Term Results Of Radiation Therapy For Prostate Cancer Recurrence Following Radical Prostatectomy The Journal of Urology. 159: 173-178. PMID 9400465 DOI: 10.1016/S0022-5347(01)64047-3 |
0.497 |
|
| 1998 |
Polascik TJ, Pound CR, DeWeese TL, Walsh PC. Comparison of Radical Prostatectomy and Iodine 125 Interstitial Radiotherapy for the Treatment of Clinically Localized Prostate Cancer: A 7-Year Biochemical (PSA) Progression Analysis Urology. 51: 884-890. DOI: 10.1016/S0090-4295(98)00153-8 |
0.476 |
|
| 1998 |
Cadeddu JA, Partin AW, DeWeese TL, Walsh PC. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy: Reply by authors The Journal of Urology. 159. DOI: 10.1016/S0022-5347(01)64049-7 |
0.515 |
|
| 1997 |
DeWeese TL, Walsh JC, Dillehay LE, Kessis TD, Hedrick L, Cho KR, Nelson WG. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation. International Journal of Radiation Oncology Biology Physics. 37: 145-154. PMID 9054890 DOI: 10.1016/S0360-3016(96)00448-8 |
0.505 |
|
| 1997 |
DeWeese TL, Bucci JM, Larrier NA, Cutler RG, Riele Ht, Nelson WG. 2023 Alteration of cellular radiation response as a consequence of defective DNA mismatch repair International Journal of Radiation Oncology Biology Physics. 39: 252. DOI: 10.1016/S0360-3016(97)80793-6 |
0.5 |
|
| 1995 |
DeWeese TL, Walsh JC, Dillehay LE, Shao Y, Kessis TD, Cho KR, Nelson WG. 158 Acute dose and low dose-rate irradiation of carcinoma cells expressing human papillomavirus E6 and E7 oncoproteins — The significance of p53, Rb and G1 arrest status International Journal of Radiation Oncology Biology Physics. 32: 220. DOI: 10.1016/0360-3016(95)97821-H |
0.442 |
|
| 1994 |
DeWeese TL, Dillehay LE, Shao Y, Williams JR. Low dose-rate sensitization of human prostate cancer cells International Journal of Radiation Oncology Biology Physics. 30: 319. DOI: 10.1016/0360-3016(94)90906-7 |
0.505 |
|
| 1991 |
DeWeese TL, Hazuka MB, Hommel DJ, Kinzie JJ, Daniel WE. AIDS-related non-Hodgkin's lymphoma: the outcome and efficacy of radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 20: 803-8. PMID 2004958 DOI: 10.1016/0360-3016(91)90027-2 |
0.305 |
|
| Show low-probability matches. |